WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 43'4801 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 63'4971 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 9'446  9'346  9'206  8'925  8'442  3'026  1'806  1'015 
Births 130  132  131  129  124  50  47  29 
Surviving infants 129  131  130  128  123  49  46  28 
Pop. less than 5 years 672  666  647  605  538  259  225  131 
Pop. less than 15 years 1'486  1'429  1'366  1'282  1'170  768  558  285 
Female 15-49 years 2'008  1'988  1'960  1'909  1'824  562  317  153 

Number of reported case

(Click for retrospective incidence data for United Arab Emirates (the))
Diphtheria 20 
Japanese encephalitis
Measles 344  132  87  69  1'187  2'796 
Mumps 354  377  396  732 
Pertussis 18  61  79  37  96  228 
Polio* 48 
Rubella 14  30  34  52 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 14 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for United Arab Emirates (the))
Vaccine year result method % card seen                                                
BCG 1994  97  FHS   72  90  94  94  98  98  15 
DTP1 1994  93  FHS   72  99*  99*  99*  94  96 
DTP3 1994  85  FHS   72  99*  99*  99*  94  94  11 
DTP4          31 
IPV1          99* 
HepB_BD          91  96  96  98  98 
HepB3 1994  76  FHS   72  99*  99*  99*  94  92 
Hib3          99*  99*  99*  94  92 
JapEnc         
MCV1          99*  99*  99*  94  94  34 
MCV2          99*  94  92 
PCV1          99*  99*  99*  94 
PCV3          99*  99*  99*  94 
Pol3 1994  86  FHS   72  99*  99*  99*  94  94  11 
Rota1          99* 
Rota_last          82 
Rubella1          99* 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for United Arab Emirates (the))
BCG 90  94  94  96  98  98  96  15 
DTP1 94  94  94  94  94  96  95  32 
DTP3 94  94  94  94  94  94  85  11 
HepB3 94  94  94  94  94  92 
HepB_BD 91  96  96  97  98  98 
Hib3 94  94  94  94  94  92 
MCV1 94  94  94  94  94  94  80  34 
MCV2 94  94  94  94  94  92 
PCV3 94  94  94  94  94 
Pol3 94  94  94  94  94  94  85  11 
Rota_last 56 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
75 
   
/
|
|
\
Greater or equal to 90% 75
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
25
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTPHibHep 4, 6 months; Yes
DTaPHib 18 months; Yes
DTaPHibHepIPV 2 months; Yes
HepB birth; 2, 4 months;
Influenza under 5 years; elderly; Yes Haj, Omrah pilgrims and risk group
MMR 12 months; 5-6 years; Yes
MenACWY Yes Haj and Omra and risk groups
OPV 4, 6, 18 months; 5-6 years; Yes
Pneumo_conj 2,4, 6, 18 months; Yes
Pneumo_ps Yes high risk groups
Rotavirus 2, 4 months; Yes
Td 15-16 years; Yes
Tdap 5-6 years; Yes
Typhoid Yes high risk groups and travellers
Varicella 12 months; Yes and risk groups
YF Yes high risk groups

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes    Yes    Yes    Yes 
What years does the MYP cover? number     5 YR        3 years 
Nº of districts with microplans that include activities to raise immunization coverage number      

System performance

Total Nº districts in country number      
Nº districts with DTP3 coverage >=80% number      
% of districts with DTP3 coverage >=80% From 0 to 100% 75    100      100 
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100% 75    100         

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes    Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    Yes        No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%             100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    Yes         

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.